The University of Washington and the University of Namibia (UNAM) recently signed a memorandum of understanding (MOU), in support of collaborative pharmacy education and training, Faculty exchange, and research between the two institutions. The memorandum was signed by Dr. Howard Frumkin, Dean of the UW School of Public Health; Dr. Thomas Baillie, Dean of the [...]
Graduate Student’s Work on Display at the Seattle Center Illustrating Pathways to Global Health
Norio Kasahara, a graduate student in the UW Pharmaceutical Outcomes Research and Policy Program and the Global Medicines Program, was featured in a video at the Seattle Center’s Global Health Experience Exhibit . The exhibit featured videos of students involved in global health projects, and Norio’s project is a medicine safety initiative in Afghanistan. Read more [...]
Global Medicines Program Partnering with VillageReach and the Barr Foundation to Improve the Supply Chain for Medicines in Malawi
The Global Medicines Program is teaming with VillageReach and the Barr Foundation to improve supply chain performance and medicines management in rural Malawi. In collaboration with the Malawi Ministry of Health and the Malawi College of Health Sciences, this three-year program will train 150 pharmacy assistants; increase supply chain capacity; and improve data management. The [...]
Professor Andy Stergachis elected to prestigious Institute of Medicine
Professor Andy Stergachis, Director of the Global Medicines Program, was one of three faculty members from the University of Washington School of Public Health elected to the prestigious Institute of Medicine, one of the highest honors in the fields of health and medicine. The inductees are among 70 new members and 10 foreign associates announced [...]
Dr. Joseph Babigumira’s Research Featured in Population Reference Bureau Research Brief
A Research Brief published by the Population Reference Bureau in September, 2012 featured research from Global Medicines Program faculty Joseph Babigumira. The Brief described key findings from two studies by Dr. Babigumira and colleagues on the cost of inducted abortion and cost-effectiveness of universal access to modern contraception: Joseph B. Babigumira et al., “Estimating the [...]
Population Reference Bureau Interview with Dr. Joseph Babigumira
Dr. Joseph Babigumira was recently interviewed about his research on the health economics of unsafe induced abortion in Uganda. Watch the Population Reference Bureau Interview here to learn more about the research.
Patents and Politics — How the HIV Crisis Changed Pharmaceutical Intellectual Property Policies: Dr. Ellen ‘t Hoen
The Global Medicines Program, along with the Department of Global Health and the Office of Graduate Medical Education, hosted Dr. Ellen ‘t Hoen for the following event: Patents and Politics — How the HIV Crisis Changed Pharmaceutical Intellectual Property Policies on Wednesday, November 14, 2012. Ellen ’t Hoen, lawyer and independent consultant in medicine policy and law, specializes [...]
Strengthening the Pharmacovigilance System in Bangladesh
On November 13-14, 2012, the Global Medicines Program participated in disseminating the results of an assessment of the pharmacovigilance and drug regulatory systems in Bangladesh. The assessment was conducted in conjunction with Management Sciences for Health with funding from the U.S. FDA and USAID through the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) [...]
Global Medicines Courses offered Spring Quarter 2013
The Global Medicines Program is pleased to announce the following courses being offered Spring Quarter 2013: PHARM 582/GH 590 – Special Topics in Global Health Pharmacy Tuesdays from 2:30pm-5:20pm, Health Sciences Building T-498 Offered in three segments, these courses provides in-depth instruction on selected special topics relating to the use, access to, cost-effectiveness and impact [...]
FDA Medwatch Newsfeed
- Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials
- Abbott Diabetes Care: Class 1 Recall - FreeStyle InsuLinx Blood Glucose Meters - Risk of Incorrect Test Result
- All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance
- Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility Assurance
- Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses
